Hbv смотреть последние обновления за сегодня на .
This video contains a detailed and simplified explanation how to test for hepatitis B and how to interpret the results of hepatitis B serology. Written notes on hepatitis can be found here: 🤍 Special thanks to Harry Watchman for editing the audio. Zero to Finals Medicine book: UK: 🤍 US: 🤍 Zero to Finals Paediatrics book: UK: 🤍 US: 🤍 Zero to Finals Obstetrics and Gynaecology book: UK: 🤍 US: 🤍 Website: 🤍 Notes: 🤍 Multiple Choice Questions: 🤍 Instagram: 🤍 Facebook: 🤍 Twitter: 🤍 DISCLAIMER: This video is for education and entertainment only, and is not medical advice. This video should NOT be used for medical advice or to guide clinical practice. The Zero to Finals content should not be used in any way to guide medical decision making. Zero to Finals takes no responsibility for any actions taken or not taken based on the information provided. Local and national guidelines and senior clinicians are there to help you make decisions, not YouTube videos. If you need medical advice or information, seek it from an appropriately trained and licenced doctor or healthcare provider that can address your individual needs. Zero to Finals cannot guarantee the accuracy of information in this video. Please highlight any errors you notice in the comments below - thank you.
Hepatitis B is a viral infection affecting the liver. The disease goes through different phases, which can be diagnosed by serology. Diagnostic testing comprises the three most important parameters: HBs antigen, anti-HBs antibody, and anti-HBc antibody. These three parameters can be used to identify active infection, previous infection, and status after vaccination. In addition, anti-HBc IgM antibodies can be used to confirm acute infection. Outline: 00:00 - Natural course of infection 03:05 - Life cycle of HBV 07:01 - Acute infection 10:41 - Chronic infection 14:50 - Markers 17:33 - Serological diagnostics
As the most common liver disease in the world, Hepatitis B is a life-threatening liver infection caused by the hepatitis B virus, or HBV. It can cause chronic infection and put people at a high risk of death from cirrhosis (scarring of the liver) and liver cancer. In 2015, 257 million people were living with a chronic form of hepatitis B, and almost 900,000 people died from it. In this video, you’ll learn a bit about the background of hepatitis B, its symptoms, transmission, molecular mechanism, prevention, and treatment! This video was made by McMaster University Demystifying Medicine students Julie Cho, Saad Ahmed, Vivek Parmar, Anisa Rana, Barjot Gill. Copyright McMaster University 2021. References: Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Vincenzo, P. D., Giuberti, T., . . . Ferrari, C. (2007). Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection. Journal of Virology, 81(8), 4215-4225. doi:10.1128/jvi.02844-06 Hepatitis B Foundation. (2020). What is Hepatitis B. 🤍 Janeway C. et al. Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science; 2001. T cell-mediated cytotoxicity. Available from: 🤍 Lumley SF, McNaughton AL, Klenerman P, Lythgoe KA and Matthews PC (2018) Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen. Front. Immunol. 9:1561. doi: 10.3389/fimmu.2018.01561 Oh, I., & Park, S. (2015). Immune-mediated Liver Injury in Hepatitis B Virus Infection. Immune Network, 15(4), 191. doi: 10.4110/in.2015.15.4.191 Schuch, A., Hoh, A., & Thimme, R. (2014). The role of natural killer cells and CD8+ T cells in hepatitis B virus infection. Frontiers in immunology, 5, 258. doi: 10.3389/fimmu.2014.00258 Seeger, C., & Mason, W. S. (2015). Molecular Biology of Hepatitis B Virus Infection. Virology, 0, 672–686. 🤍 WHO. (2020). Hepatitis B. 🤍 Ye, B. et al. (2015). T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death & Disease, 6(3), e1694-e1694. doi: 10.1038/cddis.2015.42
Hepatitis B virus tricks the immune system in a way that is unique compared with other pathogens. It does this by creating extra viral surface proteins during replication of whole virus particles. Although these additional surface proteins do not cause disease, they flood the bloodstream, acting as decoys. When our immune system creates antibodies to stop the infection, many of the antibodies bind to the extra proteins rather than binding to the whole virus particles. The whole hepatitis B virus particles can then go on to infect more liver cells. Play a Kahoot! trivia game based on this animation. Visit 🤍 Dr. Maurice Hilleman was the first to realize that these extra viral surface proteins could be used against the virus. Watch a clip from the documentary, “HILLEMAN: A Perilous Quest to Save the World’s Children,” to learn more: 🤍 Animation created by and for the Vaccine Makers Project. The Vaccine Makers Project gratefully acknowledges the ongoing collaboration and partnership with XVIVO, creator of medical animations and scientific media: 🤍. Copyright © 2016, Medical History Pictures, Inc. All rights reserved. The Vaccine Makers Project (VMP) is the classroom-based program of the Vaccine Education Center at the Children’s Hospital of Philadelphia (VEC at CHOP). The Center’s team is composed of scientists, physicians, mothers and fathers devoted to the study and prevention of infectious diseases. The Center was launched in October 2000 to provide accurate, comprehensive and up-to-date information about vaccines and the diseases they prevent. The VMP program is committed to public education about vaccine science via scientifically supported, historically accurate, and emotionally compelling content. Access the VMP’s free classroom materials: 🤍. Find information and resources related to vaccines and their safety: 🤍. Learn more about the award-winning documentary for which the original animations were created. The documentary tells the compelling story of one of the world’s most accomplished scientists, Maurice Hilleman: 🤍.
What is a hepatitis B virus?" This short animated film clarifies and informs. There is a vaccination for HBV. Timely treatment reduces the risk of cirrhosis or liver cancer. Two treatment methods are available today for patients with HBV.
Viruses are self-replicating nano-machines that stride the border between living and non-living. The hepatitis B virus in its chronic form can nest in the liver for years, sometimes as a tiny fragment of cyclic DNA. It is estimated that about 360 million people worldwide have chronic HBV infection, 75 percent being in Asia. Roche pRED (Pharma Research & Early Development) has active research programs targeting the hepatitis B virus. For more information visit 🤍 More videos on 🤍
Hepatitis B is one of the most complicated infections to diagnose. For more Doc Schmidt content, check out my website: 🤍 Want me to make you a personalized video for you or your friend? Check me out on Cameo! 🤍 Want to connect with me and watch more content? Find me on TikTok! 🤍 And Instagram! 🤍 All content is intended as medical education or entertainment and is NOT intended to be medical advice. If you have any symptoms concerning you, please schedule an appointment with your doctor. Join my channel to get access to perks! Click link below: 🤍
Hepatitis B virus | Structure, replication, transmission - This virology lecture explains about the Hepatitis B virus | Structure, replication, transmission. Hepatitis B virus (HBV) is a serious global health problem. Each year, 1.34 million people die from HBV-related liver diseases. Most of those who die are children under the age of 5. This video provides information on hepatitis B, including the causes, symptoms, and treatments. This video is about a virus that can cause liver damage, called hepatitis B. It covers how the virus is spread, what symptoms to look out for, and how to get medical help if you think you might have contracted it. This is a video about the Hepatitis B virus. The video will talk about what the virus is, how it is spread, who is at risk for getting the virus, and the symptoms of the virus. This is a public service announcement video on the Hepatitis B virus. The video will inform you on what the virus is, how it is spread, the symptoms, and how to protect yourself. If you are sexually active, have multiple partners, or are a drug user, it is important that you watch this video. For more information, log on to- 🤍 Get Shomu's Biology DVD set here- 🤍 Download the study materials here- 🤍 Remember Shomu’s Biology is created to spread the knowledge of life science and biology by sharing all this free biology lectures video and animation presented by Suman Bhattacharjee in YouTube. All these tutorials are brought to you for free. Please subscribe to our channel so that we can grow together. You can check for any of the following services from Shomu’s Biology- Buy Shomu’s Biology lecture DVD set- 🤍shomusbiology.com/dvd-store Shomu’s Biology assignment services – 🤍shomusbiology.com/assignment -help Join Online coaching for CSIR NET exam – 🤍shomusbiology.com/net-coaching We are social. Find us on different sites here- Our Website – 🤍shomusbiology.com Facebook page- 🤍 Twitter - 🤍 SlideShare- 🤍slideshare.net/shomusbiology Google plus- 🤍 LinkedIn - 🤍 Youtube- 🤍 Thank you for watching the virology lecture on Hepatitis B virus | Structure, replication, transmission.
What is viral hepatitis? Viral hepatitis is defined as inflammation of the liver parenchyma and it is most commonly caused by hepatitis viruses A, B, C, D, and E. Find our full video library only on Osmosis Prime: 🤍 Join over 3 million current & future clinicians who learn by Osmosis, and over 130 universities around the world who partner with us to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you to succeed in school, on board exams, and as a future clinician. Sign up for a free trial at 🤍 If you're interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo. Follow us on social: Facebook: 🤍 Twitter: 🤍 Instagram for med: 🤍 Instagram for nursing: 🤍 Linkedin: 🤍 Our Vision: Everyone who cares for someone will learn by Osmosis. Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: 🤍 Medical disclaimer: Knowledge Diffusion Inc (DBA Osmosis) does not provide medical advice. Osmosis and the content available on Osmosis's properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed health care provider. Always seek the advice of a physician or other qualified healthcare provider with any questions you have regarding a medical condition. © 2023 Elsevier. All rights reserved.
When it comes to HBV and pregnancy, the viral load can be a determining factor in the course of the disease. From risk assessment to treatment decisions, HBV viral load is a crucial parameter in managing pregnant women with hepatitis B. Watch the recent video of Dr. Amit Singh, Consultant Microbiologist, NRL Noida. In the video, he shared a recent case study where a pregnant woman is positive with HBsAg positive, what can be the next step, how we perform the test, and highlights its importance in ensuring healthy outcomes for both mother and baby. #bestpathologylabs #bestdiagnosticcentre - Book your test : 🌐 🤍 📞 9289589001, 898 898 8787 Read the Blogs- 🤍 - About Redcliffe Labs: We help doctors and patients to plan an accurate and appropriate treatment by helping them with the right diagnosis for a particular medical condition. We are available around the clock to provide our patients with highly competent, evidence-based and state-of-the-art diagnostic expertise. For more updates follow us on:- Facebook:- 🤍 Instagram:- 🤍 LinkedIn:- 🤍 Twitter:- 🤍 Website:- 🤍 Book your appointment at +91-8988988787, for any queries mail us at care🤍redcliffelabs.com
In this video, in plain simple language, I discuss hepatitis B virus infection (HBV) - whom to treat, when to treat, and when to stop treatment. Does everyone with HBsAg+ve require treatment? Is there a cure for HBV? Can HBV-related cirrhosis be reversed? Sources: HBV treatment guidelines from major clinical societies: American Association for Study of Liver Diseases (AASLD) 🤍 European Association for Study of the Liver (EASL) 🤍 Asia-Pacific Association for the Study of Liver (APASL) 🤍 Stopping HBV treatment in chronic HBV patients (APASL guidelines update) 🤍 Reversing HBV-related cirrhosis: 1. Liver Fibrosis Reversion After Suppression of Hepatitis B Virus 🤍 2. Reversibility of hepatitis B virus cirrhosis after therapy: who and why? 🤍 3. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B 🤍 4. Long-term therapy of chronic hepatitis B reverses cirrhosis 🤍 5. Reversal of Hepatitis B Cirrhosis Complicated by Hepatic Decompensation 🤍 A cure for HBV infection: 1/ 🤍 2/ 🤍 3/ 🤍 4/ 🤍 5/ 🤍 TheLiverDoc channel aims to provide the latest updates from scientific literature, through simple, easily understandable discussions, regarding healthcare practices in persons with liver disease Follow TheLiverDoc Twitter 🤍theliverdr Instagram 🤍abbyphilips This video is fundamentally based on: Article 51A[h] of The Constitution of India: It shall be the duty of every citizen of India to develop the scientific temper, humanism, and the spirit of inquiry and reform. Host: Dr. Abby Philips M.D., D.M (Clinical Scientist, Hepatology) at Rajagiri Hospital, Aluva, Cochin, Kerala, India Email: theliverdr🤍gmail.com or abbyphilips🤍theliverinst.in 'The Liver Doc' logo by Yeh! (Indonesia) 'The Liver Doc' logo animation by Navas Video editing on Adobe Premier Pro Video shot on Panasonic Lumix S5, 50/1.8 lens Computer rig - Customized by 🤍themvp.in
This four-minute animation introduces the life cycle of hepatitis B virus, which is responsible for a major and serious communicable and infectious disease, hepatitis B. Hopefully, this film helps making sense of antiviral medications as they take effects on the process of the life cycle of the virus. For a free and comprehensive learning experience, please go to: 🤍
In this video, ICE-HBV Chair Fabien Zoulim, Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 talks about the implementation of a Hepatitis B cure, answering: How possible is a cure for Hepatitis B? This is part of the new video series - HBV Cure FAQs: All you need to know to understand HBV research. The HBV Cure FAQs are a new tool aimed at empowering the community by equipping them with the knowledge needed to understand research for a Hepatitis B (HBV) cure that is taking place for their benefit. It is a collection of short videos answering key questions relating to HBV cure research. It is a product of an international consortium of organizations and expert institutions working in and around hepatitis B. The organizations involved are ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, TherVacB, IP-cureB, and the Canadian HBV Network.
Fb group: 🤍 In this video, Dr. Aizaz explains the life cycle or replicative cycle of the Hepatitis B virus and its modes of spread. Website: 🤍 Email: draizaz🤍medicovisual.com
The event was aimed at scientists, clinicians, and pharmaceutical and diagnostic industry representatives. The symposium, chaired by Mala Maini and Antonio Bertoletti, debated challenges surrounding immunotherapies for HBV and discussed ways forward.
«Was ist ein Hepatitis B Virus?» Dieser kurze Animationsfilm klärt auf und informiert. Für HBV gibt es eine Schutzimpfung. Eine rechtzeitige Behandlung reduziert das Risiko für Zirrhose oder Leberkrebs. Für Patienten mit HBV stehen heute zwei Behandlungsmethoden zur Verfügung.
When you have hepatitis B, which is caused by the hepatitis B virus, you may feel only slightly uncomfortable from the symptoms, or you could experience symptoms that make you feel pretty sick. Signs and symptoms of hepatitis B typically start to appear from one to four months after you've been infected, although it's possible you could begin to notice them in as little as two weeks. This video describes how you're likely to feel when you have a hepatitis infection. Do you know anyone who has had, or have you ever had, a hepatitis infection. What did it feel like, and what were the symptoms. Feel free to comment below.👇 Please share this video, and thanks for watching "How Does Hepatitis B Make You Feel?" SUBSCRIBE for more fascinating health, nutrition, pet care and travel tips 🔔► 🤍 FACEBOOK ➡️➡️ 🤍 PINTEREST ➡️➡️ 🤍 TWITTER ➡️➡️ 🤍 Other videos and webpages about how hepatitis B makes you feel: What you need to know about Hepatitis B 🤍 Is Hepatitis B Contagious? 🤍 Hepatitis B - Mayo Clinic 🤍 Keywords How Does Hepatitis B Make You Feel, hepatitis symptoms, signs of hepatitis, hepatitis B virus, HBV, jaundice, How does hepatitis B affect the body, Does hepatitis B make you tired, Do you feel sick with hepatitis B, hepatitis B vaccine
Latest Research On Hepatitis B Cure | Hepatitis B | Hepatitis Treatment About this Video = There are many research going on hepatitis b, you will also learn in this video about the latest research on hepatitis b cure. HBV hijacks a cell’s molecular machinery in order to reproduce, but its process is a bit unusual. Once inside the nucleus, it uses that machinery to first transcribe its DNA to RNA, and then converts into a new viral genome called (covalently closed circular DNA). So, this is a very good information for you guys please watch this video till end. The Rice’s Laboratory of Virology and Infectious Disease, research on HBV and HCV are quite different. They told on latest research on hepatitis b cure and both viruses are totally different from each other and have different genetic compositions. Current HBV therapies, can cause intolerable side effects or have limited impact, leading to lifelong drug therapy. Now some advanced therapeutic vaccines are available which are very effective and that can block new HBV infections. Please support our channel, if you are new to our channel, please like, share, and subscribe our channel and press the bell icon to get the new video updates. Your Queries are = hepatitis blood test, hepatitis b blood test, anti viral blood test, hbv blood, test, hepatitis, hepatitis b, hbsab, liver diseases, ascites, liver damage, alkaline foods diet, alkaline, vaccine, hepatitis b vaccine, hbv vaccine, acute hepatitis infection, chronic hepatitis infection, albumin, alpha-fetoprotein, afp, antibody, anti-hcv, antigen, ascites, bilirubin, carcinoma, chronic hepatitis b infection, cirrhosis, clinical trials, complete lood count, cbc, dna polymerase, coinfection, encephalopathy, fatty liver, fibrosis, gastroenterology, genotype, hbv dna, hepatocyte, hepatology, igg anti-hbc, igm anti-hbc, jaundice, liver biopsy, liver enzymes, liver function tests, lft, pcr, platelets, seroconversion, vaccine, viral hepatitis, viral load, virus, sgot, sgpt latest research on hepatitis b cure, Best Videos = Advanced Hepatitis B Vaccine Market Report 🤍 Best Foods for Kidney Diseases 🤍 Hepatitis B Cause Type-2 Diabetes 🤍 Does Exercise Help Hepatitis B? 🤍 How Bhumi Amla Works for Hepatitis B English 🤍 Hepatitis B Vaccine may Prevent your Baby from Liver Cancer 🤍 Guide to Hepatitis B : 🤍 Health & Fitness: 🤍 Popular Uploads: 🤍 Follow us on: = Instagram: 🤍 For Business Enquiries: hellogreatwisdom🤍gmail.com #greatwisdomofhealth #hepatitis #hepatitisb #liverdiseases #hbv #clinicaltrials #nasvac #hbvvaccine
"Cos'è il virus dell'epatite B?". Questo breve film d'animazione chiarisce e informa. Esiste una vaccinazione per l'HBV. Il trattamento tempestivo riduce il rischio di cirrosi o di cancro al fegato. Oggi sono disponibili due metodi di trattamento per i pazienti con HBV.
Current antivirals cannot cure HBV on their own. ADRI-2F3 is a fully human mAb that completely neutralize HBV, removing excess virus and restoring HBV-specific immune responses. This will allow antiviral drugs to be more efficient in HBV eradication. ADRI-2F3 can also be used to prevent mother-to-child HBV transmission, before vaccination, and to prevent HBV reinfection after liver grafts. ━━━━━━━━━━━━━━━━━━━━ Additional Information ──────────────────────────── 🤍 ━━━━━━━━━━━━━━━━━━━━ Social Media ──────────────────────────── 🤍 ━━━━━━━━━━━━━━━━━━━━ Science Animated ──────────────────────────── 🤍 🤍 🤍 🤍 ━━━━━━━━━━━━━━━━━━━━ #antibody #hbv #antibodies ━━━━━━━━━━━━━━━━━━━━
In this episode, Shie-Liang Hsieh and Tsung-Yu Tsai explain that HBV interacts with SIGLEC-3 and causes impairment of host immunity. Blocking HBV-SIGLEC-3 interaction has the potential to treat chronic HBV infection.
In this video, Chari Cohen, President of the Hepatitis B Foundation answers the question: How do we sign up for HBV and HDV clinical trials? This is part of the new video series - HBV Cure FAQs: All you need to know to understand HBV research. The HBV Cure FAQs are a new tool aimed at empowering the community by equipping them with the knowledge needed to understand research for a Hepatitis B (HBV) cure that is taking place for their benefit. It is a collection of short videos answering key questions relating to HBV cure research. It is a product of an international consortium of organizations and expert institutions working in and around hepatitis B. The organizations involved are ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, TherVacB, IP-cureB, and the Canadian HBV Network.
"Was ist HBV?" In diesem Interview klärt uns Prof. Semmo auf wie man sich gegen den HBV schützen kann. Denn mit über 257'000'000 Ansteckungen weltweit, steht die HBV an erster Stelle der viralen Lebererkrankungen und die Tendenz ist immer noch steigend. Prävention in Form der Impfung kann auch Sie schützen! Weitere Informationen: 🤍
HBV stands for Hepatitis B virus, which is a virus that can cause liver inflammation, or hepatitis B. HBV is a DNA virus that is a member of the Hepadnaviridae family. It is transmitted through exposure to infected blood or other bodily fluids, including semen, vaginal secretions, and saliva. The symptoms of hepatitis B can range from mild to severe, and they can include fever, fatigue, nausea, vomiting, abdominal pain, dark urine, and jaundice. Some people may not have any symptoms at all, but they can still transmit the virus to others. Hepatitis B can be acute, meaning that it is a short-term illness that goes away on its own within a few weeks to a few months. However, some people may develop chronic hepatitis B, which is a long-term infection that can lead to liver damage, cirrhosis, and liver cancer. #tothepoint #shorts #virology
Hepatitis B is a viral infection that attacks the liver, and can cause both, acute and chronic disease. The virus can be spread through contact with blood, or other body fluids during sex with an infected partner, unsafe injections or exposures to sharp instruments. But most commonly, transmission happens from mother to child during birth and delivery. In highly endemic areas, hepatitis B can spread horizontal transmission, especially from an infected child to an uninfected child during the first 5 years of life. That’s why, in many country, newborns are vaccinated on Hepatitis B. Hepatitis B can be almost 100 % prevented by vaccines, that are safe, available and effective. Hepatitis B is also spread by needlestick injury, tattooing, piercing and exposure to infected blood and body fluids, such as saliva and menstrual, vaginal and seminal fluids. Sexual transmission is more prevalent in unvaccinated persons with multiple sexual partners. Acquiring Hepatitis B in childhood is more dangerous. Because, Hepatitis B infection acquired in adulthood leads to chronic hepatitis in less than 5% of cases, whereas, infection in infancy and early childhood leads to chronic hepatitis in about 95% of cases. The hepatitis B virus can survive outside the body for at least 7 days. During this time, the virus can still cause infection if it enters the body of a person who is not protected by the vaccine. The incubation period of the hepatitis B virus ranges from 30 to 180 days, But The virus may be detected in the blood within 30 to 60 days after infection. Most people do not experience any symptoms when newly infected. Acute symptoms: Most people do not have any symptoms but in which who has symptoms include: yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting and abdominal pain. People with acute hepatitis can develop acute liver failure, which can lead to death, but such cases are rare, More than 95% of people who become infected as adults or older children will stage a full recovery and develop protective immunity to the virus. Long Term complications include: a subset of persons develops advanced liver diseases such as cirrhosis and hepatocellular carcinoma, which cause high morbidity and mortality. The tests, called assays, for detection of hepatitis B virus infection involve serum or blood tests that detect either viral antigens (proteins produced by the virus) or antibodies produced by the host. The hepatitis B surface antigen (HBsAg) is most frequently used to screen for the presence of this infection. Acute hepatitis B infection does not usually require treatment and most adults clear the infection spontaneously. Early antiviral treatment may be required in fewer than 1% of people. whose infection takes a very aggressive course (fulminant hepatitis) or who are immunocompromised. Chronically infected individuals with persistently elevated serum alanine aminotransferase, a marker of liver damage. There is no specific treatment for acute hepatitis B. Therefore, care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids lost from vomiting and diarrhoea. Most important is the avoidance of unnecessary medications. Acetaminophen, paracetamol and medication against vomiting should be avoided. As of 2018, there are eight medications licensed for the treatment of hepatitis B infection in the United States. These include antiviral medications lamivudine, adefovir, tenofovir disoproxil, tenofovir alafenamide, telbivudine, and entecavir, and the two immune system modulators interferon alpha-2a and PEGylated interferon alpha-2a. Treatment lasts from 6 months to 1 Year. Treatment can slow the progression of cirrhosis, reduce incidence of liver cancer and improve long term survival. WHO recommends that all infants receive the hepatitis B vaccine as soon as possible after birth, preferably within 24 hours, followed by 2 or 3 doses of hepatitis B vaccine at least 4 weeks apart to complete the vaccination series. Protection lasts at least 20 years and is probably lifelong. The disease is most common in the Western Pacific (6.2%) and African (6.1%) regions. In Europe rates are 1.6% and in the Americas they are 0.7%.
Official Ninja Nerd Website: 🤍 Ninja Nerds! In this lecture Professor Zach Murphy will be teaching you about the pathophysiology and clinical presentation of viral hepatitis A, B, C, D, E. We hope you enjoy this lecture and be sure to support us below! References: Furtado, I., Valadares, D., & Nery, F. G. (2017). Acute hepatitis B virus infection and severe non-immune haemolytic anaemia: a rare relationship. BMJ case reports, 2017, bcr2017221763. 🤍 Join this channel to get access to perks: 🤍 APPAREL | We are switching merchandise suppliers. DONATE PATREON | 🤍 PAYPAL | 🤍 SOCIAL MEDIA FACEBOOK | 🤍 INSTAGRAM | 🤍 TWITTER | 🤍 🤍NinjaNerdSci DISCORD | 🤍 #ninjanerd #Hepatitis #Gastrointestinal
Lecture: Management of HBV - Test & Treat Strategy Speaker: Hailemichael Desalegn, MD St. Paul's Hospital Millennium Medical College, Ethiopia Presented at: Conference on Liver Disease in Africa (COLDA) 2020 Learn more about the Conference on Liver Disease in Africa (COLDA) 2021 that will take place from 9 September 2021 to 11 September 2021 via 🤍 Organized by the SHARE Global Health Foundation in close collaboration with regional societies, COLDA 2021 aims at empowering healthcare professionals (HCPs) to diagnose, prevent, treat and achieve a cure for liver diseases for the benefit of patients in Africa. This being the 4th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with support from an international community of experts, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context. We aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and debates with ample time for discussion. We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge, and experience a wide spectrum of topics related to liver disease. Registration for the 2021 webinar is open and fee is waived for healthcare professionals via 🤍 For the Enduring Materials of the 2020 edition visit 🤍 For more medical education programs, as well as the latest scientific information, visit 🤍
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement Speaker: Fabien Zoulim, MD, PhD Presented at Session 1: Clinical Update on HBV Cure International Workshop on HBV Cure 2017 For more medical education programs, as well as the latest scientific information, visit 🤍 Register for our platform: 🤍 Sign up for our newsletter: 🤍 Upcoming meetings: 🤍
Hi, Welcome to Great Wisdom Discover YouTube channel. Overview = NASVAC earlier it was known as HeberNasvac®. It has shown to be safe and to have immunomodulating and antiviral properties against chronic hepatitis B virus About this Video = NASVAC is an immune therapy of finite duration, which is brilliant with continued antiviral and liver protection properties in CHB patients. NASVAC has shown to be safe and to have immunomodulating and antiviral properties in phases I, II, and III clinical trials. Recently, safety and efficacy of NASVAC have been confirmed in normal individuals and patients with CHB in Japan. NASVAC or HeberNasvac® is a liquid formulation comprising the hepatitis B surface antigens (HBsAg) and the nucleocapsid core, HBcAg of the hepatitis B virus. Please support our channel, if you are new to our channel, please like, share, and subscribe our channel and press the bell icon to get the new video updates. Your Queries are = hepatitis hepatitis b hepatitis b cure latest news 2023 hepatitis b treatment hbv cure news 2023 nasvac medicine price in bangladesh hbsab liver diseases ascites liver damage ascites treatment nasvac therapeutic medicine HeberNasvac, hebernasvac, Best Videos = Best Foods for Kidney Diseases 🤍 Hepatitis B Cause Type-2 Diabetes 🤍 Does Exercise Help Hepatitis B? 🤍 How Bhumi Amla Works for Hepatitis B English 🤍 Hepatitis B Vaccine may Prevent your Baby from Liver Cancer 🤍 Guide to Hepatitis B : 🤍 Health & Fitness: 🤍 Popular Uploads: 🤍 Follow us on: = Instagram: 🤍 For Business Enquiries: hellogreatwisdom🤍gmail.com #greatwisdomofhealth #hepatitis #hepatitisb #liverdiseases #hbv #clinicaltrials #nasvac #hbvvaccine
Vídeo sobre o ciclo de vida do VHB. Belém, 2008.
To license this video for patient education or content marketing, visit: 🤍 Ref: ANH13094 This video, created by Nucleus Medical Media, describes Hepatitis A and B. This animation begins by showing a healthy liver and explaining its function. The animation then goes on to explain the causes of Hepatitis A and B, how these viruses may be transmitted, the effects the virus can have on the liver as well as possible treatments. #HepatitisA #HepatitisB #Liver
Malattia subdola ed insidiosa, spesso difficile da identificare, ma quando si manifesta, per il fegato sono cavoli amari, perchè anche se trattabile, non va assolutamente sottovalutata. øShop I nostri design: 🤍 øSocial Facebook: 🤍 Instagram: 🤍 Sito Web: 🤍
Sansure HBV Nucleic Acid One Step Fast Release Method could offer you a fast and accurate HBV DNA result, which is the right choice for the middle or high workload molecular diagnostic laboratory.